105 related articles for article (PubMed ID: 3802704)
21. Pharmacological basis for antihypertensive effects of intravenous labetalol.
Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
[TBL] [Abstract][Full Text] [Related]
22. Effect of carvedilol on venous return: a mechanism of reduction in blood pressure.
Ishibashi T; Okuhira M; Hamaguchi M; Katsumata N; Nakazawa M; Imai S
Jpn J Pharmacol; 1991 Jan; 55(1):186-9. PubMed ID: 1674971
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.
Abbott JA; Broadstone RV; Ward DL; Pyle RL
Am J Vet Res; 2005 Apr; 66(4):637-41. PubMed ID: 15900944
[TBL] [Abstract][Full Text] [Related]
24. Beta blockade by oral propranolol and labetalol.
Cubeddu LX; Carr ME; Fuenmayor NJ
Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
[TBL] [Abstract][Full Text] [Related]
25. Actions of dilevalol on adrenoceptors.
Louis WJ; Drummer OH; Tung LH
J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S5-11. PubMed ID: 2464095
[TBL] [Abstract][Full Text] [Related]
26. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
[TBL] [Abstract][Full Text] [Related]
27. Concurrent antagonism of isoproterenol and norepinephrine after labetalol.
Richards DA; Prichard BN
Clin Pharmacol Ther; 1978 Mar; 23(3):253-8. PubMed ID: 627129
[TBL] [Abstract][Full Text] [Related]
28. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
29. Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
Kogure H; Hosaka A; Abiko Y
Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):109-22. PubMed ID: 6268004
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
Bartsch W; Sponer G; Strein K; Böhm E; Hooper RG
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S49-51. PubMed ID: 2454367
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
32. Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.
Massart PE; Donckier J; Kyselovic J; Godfraind T; Heyndrickx GR; Wibo M
Hypertension; 1999 Dec; 34(6):1197-201. PubMed ID: 10601118
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activity.
von Möllendorff E; Abshagen U; Akpan W; Neugebauer G; Schröter E
Clin Pharmacol Ther; 1986 Jun; 39(6):677-82. PubMed ID: 2871958
[TBL] [Abstract][Full Text] [Related]
34. Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats.
Gellai M; DeWolf R; Ruffolo RR
Pharmacology; 1990; 41(4):200-6. PubMed ID: 2080230
[TBL] [Abstract][Full Text] [Related]
35. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological effects of labetalol in man.
Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
[TBL] [Abstract][Full Text] [Related]
37. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Lindenfeld J; Lowes BD; Bristow MR
Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826
[TBL] [Abstract][Full Text] [Related]
38. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
[TBL] [Abstract][Full Text] [Related]
39. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
40. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
Palluk R; Hoefke W
Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
